InVivoMAb Anti-Mouse IFN-gamma Antibody (XMG1.2) (MF813010)

Name: InVivoMAb Anti-Mouse IFN-gamma Antibody (XMG1.2)
Brand: abinScience
SKU: MF813010
Price: 370 USD
Availability: InStock

Fiche technique Partager le produit Copier les informations

Prix(USD) :

Spécification :

100ug
1mg

Nombre :

Contactez-nous

Aperçu
Images
Reférences
Fiche technique
SDS

Aperçu

Numéro de catalogue	MF813010
Description	InVivoMAb Anti-Mouse IFNG/IFN-gamma Antibody (XMG1.2) [XMG1.2] (MF813010) is a rat monoclonal antibody detecting IFN-gamma in FCM, in vivo study. Suitable for Mouse. Highlights ●Flow Cytometry — Validated for flow cytometry applications.
Reactivité des espèces	Mouse
Applications	FCM, in vivo study
Espèce hôte	Rat
Clonalité	Monoclonal
Isotype	IgG
ID de clone	XMG1.2
Cible	IFN-gamma, Ifng, Interferon gamma
Niveau d'endotoxines	< 1 EU/mg
Pureté	>95% as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Numéro d'accès	P01580
Forme	Liquid
Tampon de stockage	0.01M PBS pH 7.4 Reférez-vous aux informations spécifiques sur le tampon dans la copie papier du datasheet ou dans le COA spécifique au lot.
Stabilité et stockage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Contexte	Interferon gamma (IFNG/IFN-gamma) is a ~17 kDa protein. Type II interferon produced by immune cells such as T-cells and NK cells that plays crucial roles in antimicrobial, antiviral, and antitumor responses by activating effector immune cells and enhancing antigen presentation. Primarily signals through the JAK-STAT pathway after interaction with its receptor IFNGR1 to affect gene regulation. Upon IFNG binding, IFNGR1 intracellular domain opens out to allow association of downstream signaling components JAK2, JAK1 and STAT1, leading to STAT1 activation, nuclear translocation and transcription of IFNG-regulated genes. Many of the induced genes are transcription factors such as IRF1 that are able to further drive regulation of a next wave of transcription. Plays a role in class I antigen presentation pathway by inducing a replacement of catalytic proteasome subunits with immunoproteasome subunits. 1. Pearl, JE. et al. (2001) Cellular immunology 211, 43-50. PMID: 11585387 2. Huang, S. et al. (1993) Science (New York, N.Y.) 259, 1742-5. PMID: 8456301 3. Baldridge, MT. et al. (2010) Nature 465, 793-7. PMID: 20535209 4. Matatall, KA. et al. (2014) Stem cells (Dayton, Ohio) 32, 3023-30. PMID: 25078851
Note	For research use only.